Pancreatic Cancer Research

ResearcherIomedico (Germany)Active in the last 2 years

Norbert Walter Marschner

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6098-1301; OpenAlex author ID A5034764832. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 5

  1. Head-to-head comparison of treatment sequences in advanced pancreatic cancer-Real-world data from the prospective German TPK clinical cohort study. Co-author DOI 10.1002/ijc.35071↗
  2. FOLFIRINOX or gemcitabine/nab-paclitaxel in advanced pancreatic adenocarcinoma: A novel validated prognostic score to facilitate treatment decision-making in r… Co-author DOI 10.1002/ijc.34271↗
  3. [Erlotinib plus Gemcitabine in metastatic pancreatic cancer: Results from a non-interventional trial]. Co-author DOI 10.1055/a-1071-8177↗
  4. Results from the prospective German TPK clinical cohort study: Treatment algorithms and survival of 1,174 patients with locally advanced, inoperable, or metast… Last author DOI 10.1002/ijc.31751↗
  5. Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pa… Co-author DOI 10.1007/s10637-010-9619-8↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Susanna Hegewisch‐Becker · 3 shared papers, 2019–2024 · strength 0.46
  2. Volker Heinemann · 1 shared paper, 2020 · strength 0.11
  3. Dirk Waldschmidt · 1 shared paper, 2020 · strength 0.11
  4. Christoph Benedikt Westphalen · 1 shared paper, 2020 · strength 0.11
  5. Beate S. Schultheis · 1 shared paper, 2012 · strength 0.03
  6. Max Ernst Scheulen · 1 shared paper, 2012 · strength 0.03
  7. Klaus B. Mross · 1 shared paper, 2012 · strength 0.03
  8. Florian Lordick · 1 shared paper, 2012 · strength 0.03
  9. Dirk Strumberg · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.